Need all Congresses? Press Enter for expanded federal results.

S 2383

New York Senate bill in Session 2025-2026.

Status: in_committee. Latest action: January 7, 2026.

Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Bill ID NY-2025-2026-S-2383
Session 2025-2026
Status in_committee
Committee Health
Senate in_committee 2026-01-07
Summary

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Sponsor
Mario Mattera
Official Source Back to Bills
Actions Timeline
Date Event Detail
2025-01-16 Introduced Bill introduced
2026-01-07 Status in_committee
2026-01-07 Latest Action In Senate Committee
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States